Originally published In Press as doi:10.1074/jbc.M205986200 on July 18, 2002
J. Biol. Chem., Vol. 277, Issue 39, 36005-36008, September 27, 2002
Polarization of Myosin II Heavy Chain-Protein Kinase C in
Chemotaxing Dictyostelium Cells*
Hila
Rubin and
Shoshana
Ravid
From the Department of Biochemistry, Hadassah Medical School,
Institute of Medical Sciences, The Hebrew University,
Jerusalem 91120, Israel
Received for publication, June 17, 2002
 |
ABSTRACT |
Eukaryotic cells need morphological polarity to
carry out chemotaxis (Parent, C. A., Blacklock,
B. J., Froehlich, W. M., Murphy, D. B., and
Devreotes, P. N. (1998) Cell 95, 81-91;
Jin, T., Zhang, N., Long, Y., Parent, C., and Devreotes,
P. N. (2000) Science 287, 1034-1036; Servant, G.,
Weiner, O. D., Herzmark, P., Balla, T., Sedat, J. W., and
Bourne, H. R. (2000) Science 287, 1037-1040), but sensing direction does not require polarization of chemoattractant receptors. When cells are exposed to a gradient of chemoattractant, activation occurs selectively at the stimulated edge. Such localized activation, transmitted by the recruitment of cytosolic proteins, may
be a general mechanism for gradient sensing by G protein-linked chemotactic systems. Here we show that in Dictyostelium
discoideum cells exposed to a cAMP gradient the myosin II heavy
chain kinase (MHC-PKC) and myosin II translocate to opposite ends of
the cell. We further show that MHC-PKC C1 domain is responsible for the localization of MHC-PKC to the cell leading edge, but it is not sufficient to promote cell polarization. Our findings suggest a
mechanism by which MHC-PKC regulates myosin II, allowing cell polarization and movement in the direction of the cAMP source.
 |
INTRODUCTION |
Chemotaxis in eukaryotic cells is mediated by changes in the
organization and function of cytoskeletal structures containing actin
and myosin II (6, 7). Studies on the role of myosin II in
Dictyostelium chemotaxis suggest that myosin II monomers undergo transient assembly into bipolar filaments that may precede recruitment into the cytoskeleton and that the cycles of myosin II
assembly and disassembly may be regulated by phosphorylation of myosin
II heavy chain (MHC)1 (8, 9).
Indeed, cAMP stimulation causes myosin II that exists as thick
filaments to translocate to the cell cortex. This translocation is
correlated with a transient increase in the rate of MHC as well as
light chain phosphorylation (8, 9). In addition, a novel protein kinase
C (MHC-PKC), which we purified and cloned from chemotactically
competent Dictyostelium cells, phosphorylates MHC in
response to cAMP stimulation (10-12). In vitro
phosphorylation of MHC by this kinase results in inhibition of myosin
II thick filament formation (11, 13).
Morphological polarity is necessary for chemotaxis by eukaryotic cells,
but it does not require receptor polarization (5). Dictyostelium chemotaxis is accompanied by asymmetric
recruitment to the cell surface of signal transduction proteins (2, 4), the cytosolic regulator of adenylyl cyclase (1, 14), and the pleckstrin
homology domain of the AKT protein kinase (15). Neutrophils also show such asymmetry when exposed to chemoattractant; the pleckstrin homology domain of the AKT protein kinase is recruited selectively to the membrane at the leading edge of the cell (3). In
addition, cytoskeletal proteins such as actin and several actin-binding proteins have been shown to transiently accumulate at the leading edge
of chemotaxing cells (16-19).
To define the spatiotemporal dynamics of MHC-PKC and myosin II that may
lead to cell polarization and directed movement in Dictyostelium we expressed GFP-tagged MHC-PKC and myosin II
in mhc-pkc null cells and myosin II null cells,
respectively. We found that in cells exposed to a cAMP gradient, the
MHC-PKC-GFP localized to the leading edge of the cell, whereas myosin
II translocated to its posterior part. These findings indicate a
mechanism whereby MHC-PKC and myosin II contribute to cell polarization
and chemotaxis.
 |
EXPERIMENTAL PROCEDURES |
Construction of Expression Vectors--
All DNA manipulations
followed standard methods (20). A MHC-PKC-GFP expression plasmid was
constructed as follows. A 1.8-kb fragment of MHC-PKC was isolated from
pBluescript-MHC-PKC (12) by digestion with
BglII-BamHI and cloned into
pDXA-Hy (21) to create pDXA-MHC-PKC. To isolate the
GFP, the plasmid pGFP10.1 containing the GFP cDNA (22) was digested
with BamHI and cloned in frame in front of the MHC-PKC to
create the expression vector pDXA-MHC-PKC-GFP. The pDXA-C1-GFP
expression plasmid was created by restricting the pDXA-MHC-PKC-GFP with
BsaBI and rendered blunt. This was followed by restriction
with XhoI, resulting in the deletion of a 1.4-kb fragment
from the 3 prime. The expression plasmid was then ligated resulting in
GFP fused in frame to a 0.4-kb fragment from the 5 prime of MHC-PKC
encoding the C1 domain. The expression plasmid pDXA-MHC-PKC
C1-GFP
was created by restriction of pDXA-MHC-PKC-GFP with BsaBI,
and EcoRI rendered it blunt. This plasmid was ligated. The
restriction resulted in the deletion of the C1 domain.
Growth of Dictyostelium Cells--
Dictyosteliumcells
were grown in HL-5 medium (23), supplemented with 60 units of
penicillin and 60 µg of streptomycin/ml at 21 °C. Transformations
were performed using the calcium phosphate procedure as described
previously (24). The mhc-pkc null cells were transformed
with either pDXA-MHC-PKC-GFP, pDXA-C1-GFP, or pDXA-MHC-PKC
C1-GFP to
create mhc-pkc-gfp, c1-gfp, and
c1-gfp cell lines respectively. The myosin II
null cell line HS1 (25) was transformed with pBigGFPmyo to create
myosin II-gfp cells (26). Transformed cells were selected
and grown in the presence of G418 at 5 µg/ml (Geneticin, Invitrogen).
Cell Development--
Amoeba of Dictyostelium
discoideum strains were grown in HL-5 medium (23), harvested at a
density of 2 × 106 cells/ml, washed twice in MES
buffer (20 mM MES, pH 6.8, 0.2 mM
CaCl2, 2 mM MgSO4), and resuspended
in MES buffer at a density of 2 × 107 cells/ml. Cells
were shaken at 100 rpm at 22 °C for 3.5 h. 5 mM
caffeine was added to the suspension 30 min prior to the addition of cAMP.
Western Blot Analysis--
Cells were developed for 4 h as
described above, washed in 10 mM Tris-HCl (pH 8.0) and 150 mM KCl, and lysed in 50 mM Tris-HCl (pH 8.0),
20 mM sodium pyrophosphate (pH 6.8), 5 mM EDTA,
5 mM EGTA, 0.5% Triton X-100, and protease inhibitor mix
(Sigma). Protein concentration was determined by the method of Peterson
(27), and the lysates were electrophoresed on SDS-PAGE (28). Western blots were probed with MHC-PKC polyclonal antibody (11) or with GFP
antibody (Santa Cruz Biotechnology, Inc.). The blots were developed
using a horseradish peroxidase-coupled secondary antibody (Bio-Rad).
ECL was performed using a kit from Amersham Biosciences.
Imaging--
4-h developed Dictyostelium amoebae
expressing MHC-PKC-GFP, C1-GFP,
C1-GFP, or myosin II-GFP (26) were
placed on a coverslip mounted on a Zigmod chamber (29), in which one
well was filled with MES buffer and the other with MES buffer
containing 1 µM cAMP. After waiting 10 min to allow
development of a gradient, the cells were observed with a Zeiss
Axiovert microscope using a Planapochromat 100y1.4 objective and a
basement port connected to a cooled charge-coupled device (CCD) camera.
Images were taken every 5 s with the shutter set at a 20-ms
exposure with a 100-watt mercury lamp attenuated by a 50% neutral
density filter to prevent light-induced damage to the cells. Images
were collected and analyzed with Image-Pro Plus (Media Cybernetics,
Silver Spring, MD).
 |
RESULTS AND DISCUSSION |
To define the spatiotemporal dynamics of MHC-PKC that may lead to
cell polarization and directed movement we expressed GFP-tagged MHC-PKC
(MHC-PKC-GFP; Fig. 1) in
mhc-pkc null cells (12). MHC-PKC-GFP rescued all
mhc-pkc null cell defects. mhc-pkc null cells
exhibit substantial myosin II overassembly in vivo, as well
as aberrant cell polarization, chemotaxis, and morphological
differentiation (12). However, expression of MHC-PKC-GFP resulted in
cells showing similar chemotaxis and differentiation properties to
wild-type cells (data not shown). These results indicate that tagging
the MHC-PKC with GFP did not affect its properties.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Western blot analysis of
mhc-pkc null cells expressing
MHC-PKC-GFP and C1-GFP, and myosin II null
cells expressing myosin II-GFP fusion proteins. Extracts from the
different cell lines were electrophoresed in 10% SDS-PAGE. The
proteins were transferred to a nitrocellulose membrane and probed with
antibodies specific to GFP.
|
|
To study the localization properties of MHC-PKC during chemotaxis
toward cAMP, mhc-pkc-gfp cells were subjected to a cAMP gradient using a Zigmond chamber (29). The chemotactic response of
mhc-pkc-gfp cells was observed at 5-s intervals 10 min after placing the coverslip containing cells in the chamber (Fig.
2). Cells freshly placed in the chamber
(time, 0 s) were round, and the MHC-PKC-GFP was distributed evenly
throughout the cytoplasm. As time progressed the cell sent lamellipodia
toward the region of high cAMP concentration and became polarized. The
localization of MHC-PKC was also altered together with the changes in
cell morphology. In a cell first subjected to a cAMP gradient, the MHC-PKC-GFP was distributed evenly throughout the cytoplasm (Fig. 2,
0-20 s), but after 25-30 s it was concentrated at the leading edge of
the cell. These results indicate that a cell moving up a cAMP gradient
achieves cell polarization as well as polarization of MHC-PKC.

View larger version (97K):
[in this window]
[in a new window]
|
Fig. 2.
Localization of MHC-PKC-GFP in live cells in
a cAMP gradient. Chemotactic response of mhc-pkc-gfp
cells was observed under Numarski optic and the fluorescence microscope
(see "Experimental Procedures"). Six Numarski and fluorescent
images were captured every 5 s, 10 min after the glass coverslips
containing the cells were placed in the Zigmond chamber.
Arrows indicate the position of the high cAMP
concentration.
|
|
To study the localization properties of myosin II in chemotaxing cells,
we expressed myosin II-GFP in myosin II null cells (Fig. 1).
Moores et al. (26) have shown that purified myosin II-GFP
protein displays wild-type myosin II properties in vitro. Furthermore, expression of myosin II-GFP fully complements the myosin
II null cell phenotype. To follow myosin II dynamics, myosin II-gfp cells were subjected to a cAMP gradient similar to that described above. As shown in Fig. 3,
30 s after exposing the cell to the cAMP gradient, the cell became
polarized sending out lamellipodia along with thin filopodia toward the
region of high cAMP concentration. At the same time most of the myosin
II-GFP became localized to the posterior part of the cell. These
results indicate that, in a cAMP gradient, Dictyostelium
cells send their MHC-PKC-GFP and myosin II-GFP to opposite ends of the
cell. These findings are consistent with experiments in polarized
Dictyostelium cells in which immunofluorescent stained
myosin II was found to be localized at the posterior part of the cell
(30-32).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Localization of myosin II-GFP in live cells
in a cAMP gradient. Experiments were as described in the legend to
Fig. 2. Arrows indicate the position of the high cAMP
concentration.
|
|
Expression of C1 from mammalian PKC results in translocation of this
domain to the cell membrane (33). This observation together with
biochemical evidence indicates that PKC binds to the cell membrane
through its C1 domain (for reviews see Refs. 34 and 35). To define the
MHC-PKC domain responsible here for binding MHC-PKC to the cell
membrane and thus enabling it to concentrate at the anterior part of
chemotaxing cells, we expressed two MHC-PKC truncation proteins tagged
with GFP in mhc-pkc null cells. The first protein was the C1
domain of MHC-PKC, and the second was MHC-PKC in which the C1 domain
had been deleted (
C1-GFP) (Fig. 1). Both cell lines were subjected
to a cAMP gradient in the Zigmond chamber (29) as described above. In
contrast to MHC-PKC-GFP, which at first appeared diffusely distributed
throughout the cytoplasm and then gradually concentrated at the leading
edge of the cell (Fig. 2), the C1-GFP appeared as small spherical
aggregates that concentrated at the cell region facing the cAMP high
concentration (Fig. 4). These results
suggest that similar to mammalian PKC, MHC-PKC binds to the cell
membrane through its C1 domain. The ability of C1 domain to localize to
the cell leading edge indicates that C1 domain possessed the
information required for the localization of MHC-PKC to this region in
a cAMP gradient. Even though C1 domain localized to the cell leading
edge, the c1-gfp cells did not undergo cell polarization or
chemotaxis; this may be because of the absence of MHC-PKC catalytic
domain that is required for cell polarization and chemotaxis (12).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
Localization of C1-GFP in live cells in a
cAMP gradient. Experiments were as described in the legend to Fig.
2. Arrows indicate the position of the high cAMP
concentration.
|
|
Deletion of the C1 domain (i.e.
C1-GFP) also resulted in
spherically shaped proteins, but in contrast to C1-GFP, the
C1-G distributed evenly throughout the cytoplasm regardless of cAMP stimulation (Fig. 5). These results
further indicate that MHC-PKC concentrates at the cell membrane in
response to cAMP stimulation using its C1 domain, and when the C1
domain is absent, the protein remains in the cytoplasm. Similar to
c1-gfp cells,
c1-gfp cells did not undergo
cell polarization and chemotaxis; this can be because of the absence of
C1 that is required for MHC-PKC binding to the cell membrane, a step
necessary for MHC-PKC activation (36). The appearance of C1-GFP and
C1-GFP in aggregates may be because of the expression of truncated
MHC-PKC proteins.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 5.
Localization of
C1-GFP in live cells expressing in a cAMP
gradient. Experiments were as described in the legend to Fig. 2.
Arrows indicate the position of the high cAMP
concentration.
|
|
The results described above indicate that exposure of
Dictyostelium cells to the cAMP gradient results in cell
polarization and localization of MHC-PKC and myosin II to opposite
sites of the cell. Furthermore, the MHC-PKC C1 domain is required for
the localization of MHC-PKC to the cell leading edge of chemotaxing cell; however the C1 protein is not sufficient for cell polarization and chemotaxis. These results fit with our previous observations in
which we biochemically followed the localization and activation of
MHC-PKC and of myosin II stimulated with cAMP (36). Based both on these
previous results and the current results, we suggest the following
model for the involvement of MHC-PKC and myosin II in cell polarization
and chemotaxis. The unstimulated cell is rounder in shape because of a
contractile shell formed by an actin-myosin II network in the cortex.
This network presumably inhibits events necessary for pseudopodial
projection. cAMP stimulation of one edge of the cell results in
activation of the cytosolic MHC-PKC, causing it to translocate to the
membrane. Here it concentrates in an active form at the site of cAMP
stimulation (i.e. the cell's leading edge). Active MHC-PKC
phosphorylates the cortical MHC at the anterior part of the cell,
causing disassembly of myosin II thick filaments. The disassembled
myosin II molecules reassemble at the posterior part of the cell, thus
providing a force that moves the cell forward.
 |
ACKNOWLEDGEMENT |
We thank Dr. J. A. Spudich for providing
GFP-myosin II expression vector and Dictyostelium myosin II
null cells.
 |
FOOTNOTES |
*
This work was supported by a grant from the Israel Academy
for Science and Humanities.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 972-2-6758283;
Fax: 972-2-6758985; E-mail: ravid@md.huji.ac.il.
Published, JBC Papers in Press, July 18, 2002, DOI 10.1074/jbc.M205986200
 |
ABBREVIATIONS |
The abbreviations used are:
MHC, myosin II heavy
chain;
PKC, protein kinase C;
GFP, green fluorescent protein;
MES, 4-morpholineethanesulfonic acid.
 |
REFERENCES |
| 1.
|
Parent, C. A.,
Blacklock, B. J.,
Froehlich, W. M.,
Murphy, D. B.,
and Devreotes, P. N.
(1998)
Cell
95,
81-91[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Jin, T.,
Zhang, N.,
Long, Y.,
Parent, C.,
and Devreotes, P. N.
(2000)
Science
287,
1034-1036[Abstract/Free Full Text]
|
| 3.
|
Servant, G.,
Weiner, O. D.,
Herzmark, P.,
Balla, T.,
Sedat, J. W.,
and Bourne, H. R.
(2000)
Science
287,
1037-1040[Abstract/Free Full Text]
|
| 4.
|
Janetopoulos, C.,
Jin, T.,
and Devreotes, P. N.
(2001)
Science
291,
2408-2411[Abstract/Free Full Text]
|
| 5.
|
Wang, M.,
Van-Haastert, P. J.,
Devreotes, P. N.,
and Schaap, P.
(1988)
Dev. Biol.
128,
72-77[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Trinkaus, J. P.
(1984)
Cell into Organs: The Force That Shapes the Embryo
, Prentice-Hall Inc., Englewood Cliffs, NJ
|
| 7.
|
Spudich, J. A.
(1989)
Cell Regul.
1,
1-11[Medline]
[Order article via Infotrieve]
|
| 8.
|
Malchow, D.,
Bohme, R.,
and Rahmsdorf, H. J.
(1981)
Eur. J. Biochem.
17,
213-218
|
| 9.
|
Berlot, C. H.,
Spudich, J. A.,
and Devreotes, P. N.
(1985)
Cell
43,
307-314[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Ravid, S.,
and Spudich, J. A.
(1989)
J. Biol. Chem.
264,
15144-15150[Abstract/Free Full Text]
|
| 11.
|
Ravid, S.,
and Spudich, J. A.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
5877-5881[Abstract/Free Full Text]
|
| 12.
|
Abu-Elneel, K.,
Karchi, M.,
and Ravid, S.
(1996)
J. Biol. Chem.
271,
977-984[Abstract/Free Full Text]
|
| 13.
|
Pasternak, C.,
Flicker, P. F.,
Ravid, S.,
and Spudich, J. A.
(1989)
J. Cell Biol.
109,
203-210[Abstract/Free Full Text]
|
| 14.
|
Parent, C. A.,
and Devreotes, P. N.
(1999)
Science
284,
765-770[Abstract/Free Full Text]
|
| 15.
|
Meili, R.,
Ellsworth, C.,
Lee, S.,
Reddy, T. B., Ma, H.,
and Firtel, R. A.
(1999)
EMBO J.
18,
2092-2105[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Westphal, M.,
Jungbluth, A.,
Heidecker, M.,
Muhlbauer, B.,
Heizer, C.,
Schwartz, J. M.,
Marriott, G.,
and Gerisch, G.
(1997)
Curr. Biol.
7,
176-183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Gerisch, G.,
Albrecht, R.,
Heizer, G.,
Hodgkinson, S.,
and Maniak, M.
(1995)
Curr. Biol.
5,
1280-1285[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Kreitmeier, M.,
Gerisch, G.,
Heizer, C.,
and Muller-Taubenberger, A.
(1995)
J. Cell Biol.
129,
179-188[Abstract/Free Full Text]
|
| 19.
|
Aizawa, H.,
Fukui, Y.,
and Yahara, I.
(1997)
J. Cell Sci.
110,
2333-2344[Abstract]
|
| 20.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 21.
|
Manstein, D. J.,
Schuster, H. P.,
Morandini, P.,
and Hunt, D. M.
(1995)
Gene (Amst.)
162,
129-134[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Chalfie, M., Tu, Y.,
Euskirchen, G.,
Ward, W. W.,
and Prasher, D. C.
(1994)
Science
263,
802-805[Abstract/Free Full Text]
|
| 23.
|
Spudich, J. A.
(1987)
Methods Cell Biol.
28,
3-8[Medline]
[Order article via Infotrieve]
|
| 24.
|
Egelhoff, T. T.,
Titus, M. A.,
Manstein, D. J.,
Ruppel, K. M.,
and Spudich, J. A.
(1991)
Methods Enzymol.
196,
319-335[Medline]
[Order article via Infotrieve]
|
| 25.
|
Ruppel, K. M.,
Uyeda, T. Q. P.,
and Spudich, J. A.
(1994)
J. Biol. Chem.
269,
18773-18780[Abstract/Free Full Text]
|
| 26.
|
Moores, S. L.,
Sabry, J. H.,
and Spudich, J. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
443-446[Abstract/Free Full Text]
|
| 27.
|
Peterson, G.
(1977)
Anal. Biochem.
83,
346-356[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Laemmli, U.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Zigmond, S. H.
(1988)
Methods Enzymol.
162,
65-72[Medline]
[Order article via Infotrieve]
|
| 30.
|
Yumura, S.,
and Fukui, Y.
(1985)
Nature
314,
194-196[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Nachmias, V. T.,
Fukui, Y.,
and Spudich, J. A.
(1989)
Cell Motil. Cytoskeleton
13,
158-169[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Chu, Q.,
and Fukui, Y.
(1996)
Cell. Motil. Cytoskeleton
35,
254-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Oancea, E.,
and Meyer, T.
(1998)
Cell
95,
307-318[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Kikkawa, U.,
Kishimoto, A.,
and Nishizuka, Y.
(1989)
Annu. Rev. Biochem.
58,
31-44[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Nakamura, S.-i.,
and Nishizuka, Y.
(1994)
J. Biochem. (Tokyo)
115,
1029-1034[Abstract/Free Full Text]
|
| 36.
|
Dembinsky, A.,
Rubin, H.,
and Ravid, S.
(1996)
J. Cell Biol.
134,
911-921[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Franca-Koh and P. N. Devreotes
Moving Forward: Mechanisms of Chemoattractant Gradient Sensing
Physiology,
October 1, 2004;
19(5):
300 - 308.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.